Zobrazeno 1 - 10
of 178
pro vyhledávání: '"Braganza N"'
Autor:
Tiwari AK; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Zai CC; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.; Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada., Altar CA; Splice Therapeutics, 20271 Goldenrod Lane, Lab 2071, Germantown, MD, 20876, USA., Tanner JA; Myriad Neuroscience, Mason, OH, USA., Davies PE; Myriad Neuroscience, Mason, OH, USA., Traxler P; Myriad Neuroscience, Mason, OH, USA., Li J; Myriad Neuroscience, Mason, OH, USA., Cogan ES; Myriad Genetics, Salt Lake City, UT, USA., Kucera MT; Myriad Genetics, Salt Lake City, UT, USA., Gugila A; Myriad Neuroscience, Mason, OH, USA., Braganza N; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Emmerson H; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Zai G; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada., Müller DJ; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada., Levitan R; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada., Kloiber S; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada., Daskalakis ZJ; Department of Psychiatry, UC San Diego, San Diego, CA, USA., Frey BN; Mood Disorders Treatment and Research Centre and Women's Health Concerns Clinic, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada.; Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada., Bowen JM; Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada.; Program for Health System and Technology Evaluation, Ted Rogers Centre for Heart Research at Peter Munk Cardiac Centre, Toronto General Hospital Research Institute (TGHRI), Hamilton, Canada.; Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network (UHN), Hamilton, Canada., Tarride JE; Department of Health Research Methods, Evidence, and Impact (HEI), Faculty of Health Science, McMaster University, Hamilton, ON, Canada.; Programs for Assessment of Technology in Health (PATH), The Research Institute of St. Joe's Hamilton, St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada.; Center for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada., Tytus R; Family Medicine, McMaster University, Hamilton, ON, Canada., Chandrasena R; Chatham-Kent Health Alliance, Chatham, ON, Canada., Voudouris N; Thornhill Medical Center, Toronto, ON, Canada., Taylor VH; Department of Psychiatry, University of Calgary, Hotchkiss Brain Institute, an Institute of the Cumming School of Medicine, Calgary, AB, Canada., Tempier R; Hôpital Montfort, Ottawa, ON, Canada.; Department of Psychiatry, University of Ottawa, Ottawa, ON, Canada., Sharma V; Department of Psychiatry, Western University, London, ON, Canada., Vasudev A; Department of Psychiatry, Geriatric Psychiatry and Neurosciences, Western University, London, ON, Canada.; Integrative Psychiatry Lab, Parkwood Institute of Mental Health, London, ON, Canada., Dzongowski P; Milestone Research, London, ON, Canada., Pliamm L; Canadian Phase Onward Inc., Polyclinic Family and Specialty Medicine Facility, Polyclinic Family Health Group, Toronto, ON, Canada., Greenspoon T; Hamilton Community Health Centre, Hamilton, ON, Canada., Dechairo BM; Myriad Genetics, Salt Lake City, UT, USA., Kennedy JL; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada. jim.kennedy@camh.ca.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. jim.kennedy@camh.ca.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. jim.kennedy@camh.ca.
Publikováno v:
Translational psychiatry [Transl Psychiatry] 2022 Mar 14; Vol. 12 (1), pp. 101. Date of Electronic Publication: 2022 Mar 14.
Autor:
Tiwari AK; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Zai CC; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.; Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada., Altar CA; Splice Therapeutics, 20271 Goldenrod Lane, Lab 2071, Germantown, MD, 20876, USA., Tanner JA; Myriad Neuroscience, Mason, OH, USA., Davies PE; Myriad Neuroscience, Mason, OH, USA., Traxler P; Myriad Neuroscience, Mason, OH, USA., Li J; Myriad Neuroscience, Mason, OH, USA., Cogan ES; Myriad Genetics, Salt Lake City, UT, USA., Kucera MT; Myriad Genetics, Salt Lake City, UT, USA., Gugila A; Myriad Neuroscience, Mason, OH, USA., Braganza N; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Emmerson H; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Zai G; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada., Müller DJ; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada., Levitan R; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada., Kloiber S; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada., Daskalakis ZJ; Department of Psychiatry, UC San Diego, San Diego, CA, USA., Frey BN; Mood Disorders Treatment and Research Centre and Women's Health Concerns Clinic, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada.; Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada., Bowen JM; Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada.; Program for Health System and Technology Evaluation, Ted Rogers Centre for Heart Research at Peter Munk Cardiac Centre, Toronto General Hospital Research Institute (TGHRI), Hamilton, Canada.; Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network (UHN), Hamilton, Canada., Tarride JE; Department of Health Research Methods, Evidence, and Impact (HEI), Faculty of Health Science, McMaster University, Hamilton, ON, Canada.; Programs for Assessment of Technology in Health (PATH), The Research Institute of St. Joe's Hamilton, St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada.; Center for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada., Tytus R; Family Medicine, McMaster University, Hamilton, ON, Canada., Chandrasena R; Chatham-Kent Health Alliance, Chatham, ON, Canada., Voudouris N; Thornhill Medical Center, Toronto, ON, Canada., Taylor VH; Department of Psychiatry, University of Calgary, Hotchkiss Brain Institute, an Institute of the Cumming School of Medicine, Calgary, AB, Canada., Tempier R; Hôpital Montfort, Ottawa, ON, Canada.; Department of Psychiatry, University of Ottawa, Ottawa, ON, Canada., Sharma V; Department of Psychiatry, Western University, London, ON, Canada., Vasudev A; Department of Psychiatry, Geriatric Psychiatry and Neurosciences, Western University, London, ON, Canada.; Integrative Psychiatry Lab, Parkwood Institute of Mental Health, London, ON, Canada., Dzongowski P; Milestone Research, London, ON, Canada., Pliamm L; Canadian Phase Onward Inc., Polyclinic Family and Specialty Medicine Facility, Polyclinic Family Health Group, Toronto, ON, Canada., Greenspoon T; Hamilton Community Health Centre, Hamilton, ON, Canada., Dechairo BM; Myriad Genetics, Salt Lake City, UT, USA., Kennedy JL; Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada. jim.kennedy@camh.ca.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. jim.kennedy@camh.ca.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. jim.kennedy@camh.ca.
Publikováno v:
Translational psychiatry [Transl Psychiatry] 2022 May 30; Vol. 12 (1), pp. 214. Date of Electronic Publication: 2022 May 30.
Autor:
Wang, Min‐Jun1,2 (AUTHOR), Wang, Yuan‐Chen1 (AUTHOR), Masson, Emmanuelle3,4 (AUTHOR), Wang, Ya‐Hui1 (AUTHOR), Yu, Dong5 (AUTHOR), Qian, Yang‐Yang1 (AUTHOR), Tang, Xin‐Ying6 (AUTHOR), Deng, Shun‐Jiang1 (AUTHOR), Hu, Liang‐Hao1 (AUTHOR), Wang, Lei1 (AUTHOR), Wang, Li‐Juan1 (AUTHOR), Rebours, Vinciane7 (AUTHOR), Cooper, David N.8 (AUTHOR), Férec, Claude3 (AUTHOR), Li, Zhao‐Shen1 (AUTHOR), Chen, Jian‐Min3 (AUTHOR) jian-min.chen@univ-brest.fr, Zou, Wen‐Bin1 (AUTHOR) dr.wenbinzou@hotmail.com, Liao, Zhuan1 (AUTHOR) liaozhuan@smmu.edu.cn
Publikováno v:
Advanced Science. 10/16/2024, Vol. 11 Issue 38, p1-18. 18p.
Autor:
Zai CC; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.; Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada., Tiwari AK; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Zai GC; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada., Freeman N; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada., Pouget JG; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Greco J; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada., Tampakeras M; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada., Shaikh SA; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada., Herbert D; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada., Emmerson H; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada., Cheema SY; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada., Braganza N; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada., Müller DJ; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada., Voineskos AN; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada., Remington G; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada., Kennedy JL; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2019 Nov 26; Vol. 10, pp. 1339. Date of Electronic Publication: 2019 Nov 26 (Print Publication: 2019).
Autor:
Walden LM; Pharmacogenetic Research Clinic, Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health, Toronto, Ontario, Canada; National University of Ireland, Galway, Ireland., Brandl EJ; Pharmacogenetic Research Clinic, Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry and Psychotherapy, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany; Berlin Institute of Health, Berlin, Germany., Tiwari AK; Pharmacogenetic Research Clinic, Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health, Toronto, Ontario, Canada., Cheema S; Pharmacogenetic Research Clinic, Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health, Toronto, Ontario, Canada., Freeman N; Pharmacogenetic Research Clinic, Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health, Toronto, Ontario, Canada., Braganza N; Pharmacogenetic Research Clinic, Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health, Toronto, Ontario, Canada., Kennedy JL; Pharmacogenetic Research Clinic, Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada., Müller DJ; Pharmacogenetic Research Clinic, Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada. Electronic address: daniel.mueller@camh.ca.
Publikováno v:
Psychiatry research [Psychiatry Res] 2019 Sep; Vol. 279, pp. 111-115. Date of Electronic Publication: 2018 Mar 09.
Publikováno v:
Oxford Journal of Legal Studies. Autumn2022, Vol. 42 Issue 3, p787-817. 31p.
Autor:
Chapman MA; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, Addenbrookes Hospital, Cambridge, United Kingdom., Sive J; Department of Haemato-oncology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom., Ambrose J; Bill Lyons Informatics Centre, UCL Cancer Institute, University College London, London, United Kingdom., Roddie C; Department of Haematology, University College London Hospitals, London, United Kingdom., Counsell N; Cancer Research UK and UCL Cancer Trials Centre, London, United Kingdom., Lach A; Department of Haematology, UCL Cancer Institute, University College London, London, United Kingdom., Abbasian M; Department of Haematology, UCL Cancer Institute, University College London, London, United Kingdom., Popat R; Department of Haematology, University College London Hospitals, London, United Kingdom., Cavenagh JD; Department of Haemato-oncology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom., Oakervee H; Department of Haemato-oncology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom., Streetly MJ; Department of Haematology, Guys and St. Thomas' Hospital, London, United Kingdom., Schey S; Department of Haematology, Kings College Hospital, London, United Kingdom., Koh M; Department of Haematology, St. George's Hospital, London, United Kingdom., Willis F; Department of Haematology, St. George's Hospital, London, United Kingdom., Virchis AE; Department of Haematology, Royal Free London, Barnet and Chase Farm Hospitals, London, United Kingdom., Crowe J; Department of Haematology, Royal United Hospitals Bath, Bath, United Kingdom., Quinn MF; Department of Haematology, Belfast City Hospital, Belfast, United Kingdom., Cook G; Department of Haematology, St. James's University Hospital, Leeds, United Kingdom., Crawley CR; Department of Haematology, Addenbrookes Hospital, Cambridge, United Kingdom., Pratt G; Centre for Clinical Haematology, University Hospitals Birmingham, Birmingham, United Kingdom., Cook M; Centre for Clinical Haematology, University Hospitals Birmingham, Birmingham, United Kingdom., Braganza N; Cancer Research UK and UCL Cancer Trials Centre, London, United Kingdom., Adedayo T; Cancer Research UK and UCL Cancer Trials Centre, London, United Kingdom., Smith P; Cancer Research UK and UCL Cancer Trials Centre, London, United Kingdom., Clifton-Hadley L; Cancer Research UK and UCL Cancer Trials Centre, London, United Kingdom., Owen RG; Haematological Malignancy Diagnostic Service, St. James' University Hospital, Leeds, United Kingdom., Sonneveld P; Erasmus Medical Centre, Rotterdam, The Netherlands; and., Keats JJ; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ., Herrero J; Bill Lyons Informatics Centre, UCL Cancer Institute, University College London, London, United Kingdom., Yong K; Department of Haematology, UCL Cancer Institute, University College London, London, United Kingdom.
Publikováno v:
Blood [Blood] 2018 Nov 15; Vol. 132 (20), pp. 2154-2165. Date of Electronic Publication: 2018 Sep 04.
Autor:
Tanner JA; Neurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Assurex Health Ltd., Toronto, ON, Canada., Davies PE; Assurex Health Ltd., Toronto, ON, Canada., Voudouris NC; Thornhill Medical Centre, Toronto, ON, Canada., Shahmirian A; Neurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada; Molecular Brain Science Research Department, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Herbert D; Neurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada; Molecular Brain Science Research Department, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Braganza N; Neurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada; Molecular Brain Science Research Department, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Gugila A; Assurex Health Ltd., Toronto, ON, Canada., Dechairo BM; Assurex Health, Inc., Mason, OH, USA., Kennedy JL; Neurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Molecular Brain Science Research Department, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. Electronic address: jim.kennedy@camh.ca.
Publikováno v:
Journal of psychiatric research [J Psychiatr Res] 2018 Sep; Vol. 104, pp. 157-162. Date of Electronic Publication: 2018 Jul 21.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hernandez, Marta1,2 (AUTHOR) martahh1@blanquerna.url.edu, Cullell, Natalia3,4 (AUTHOR) ncullell@mutuaterrassa.cat, Cendros, Marc5 (AUTHOR) mcendros@gmail.com, Serra-Llovich, Alexandre3 (AUTHOR) alexserra@mutuaterrassa.cat, Arranz, Maria J.1,3 (AUTHOR) mjarranz@mutuaterrassa.es
Publikováno v:
Pharmaceutics. Feb2024, Vol. 16 Issue 2, p244. 23p.